E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/21/2010 in the Prospect News PIPE Daily.

New Issue: Dyax announces plans for $2.5 million placement of common stock

By Devika Patel

Knoxville, Tenn., June 18 - Dyax Corp. arranged a $2.5 million private placement of stock on June 18, according to an 8-K filed Monday with the Securities and Exchange Commission.

The company will sell 636,132 common shares to Sigma-Tau SpA at $3.93 per share, a 50% premium to the June 18 closing stock price of Dyax.

Dyax is a pharmaceutical company based in Cambridge, Mass.

Issuer:Dyax Corp.
Issue:Common stock
Amount:$2.5 million
Shares:636,132
Price:$3.93
Warrants:No
Investor:Sigma-Tau SpA
Pricing date:June 18
Stock symbol:Nasdaq: DYAX
Stock price:$2.62 at close June 18
Market capitalization:$256 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.